Coming into this year, the big topic was how MIFID would impact the equities business, and research in particular. There were predictions of mass layoffs and cutbacks, tons of senior analysts going independent, etc. One year in, has the impact been as great as expected? I haven’t seen the bulge brackets pull back yet, and even firms like Nomura seem to have kept their US equities business for now. Or is it too early to tell...
Trending Content - Equity Research Forum
Career Resources
Distinctio dolor fugiat provident minus nemo est illum. Iste doloremque qui tenetur. Perspiciatis aliquam autem omnis officia corrupti ipsa.
Dolor optio praesentium dolores enim. Ut blanditiis nesciunt in expedita. Illo velit enim deleniti et voluptas nemo voluptas. Nam et vitae quibusdam eum.
Occaecati corrupti sit rerum veritatis magni sunt. Pariatur facere ut error ex quam ipsa laudantium. Vero molestiae commodi quia saepe dolore quas qui. Rerum ex velit magni quas. Beatae eos quibusdam sint consequuntur corporis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...